英文論文

    題名 著者 誌名 巻(号):頁-頁, 年
2021 1 Factors influencing the quality of life in patients with severe dementia. Nagata Y, Nishikawa T, Tanaka H, Ishimaru D, Ogawa Y, Fukuhara K, Shigenobu K, Ikeda M Psychogeriatrics. 2022 Jan; 22(1):49-54
2 Decreased frontotemporal connectivity in patients with parkinson's disease experiencing face pareidolia. Kajiyama Y, Hattori N, Nakano T, Revankar GS, Otomune H, Hashimoto R, Mori E, Ikeda M, Mihara M, Mochizuki H NPJ Parkinsons Dis.;7(1):90. 2021.10. 7
3 Experts' perception of support for people with dementia and their families during the COVID-19 pandemic Kazawa K, Akishita M, Ikeda M, Iwatsubo T, Ishii S Geriatr Gerontol Int. 2022 Jan;22(1):26-31. 2021.11. 9.
4 Impact of Behavioral and Psychological Symptoms on Caregiver Burden in Patients With Dementia With Lewy Bodies Kanemoto H, Sato S, Satake Y, Koizumi F, Taomoto D, Kanda A, Wada T, Yoshiyama K, Ikeda M Front Psychiatry.;12:753864. .2021 10.27
5 Characteristics of behavioral symptoms in right-sided predominant semantic dementia and their impact on caregiver burden: a cross-sectional study. Sato S, Hashimoto M, Yoshiyama K, Kanemoto H, Hotta M, Azuma S, Suehiro T, Kakeda K, Nakatani Y, Umeda S, Fukuhara R, Takebayashi M, Ikeda M Alzheimer's research & therapy 13(1) 166-166 2021.10.9
6 Characteristics of Adaptation in Undergraduate University Students Suddenly Exposed to Fully Online Education During the COVID-19 Pandemic Ishimaru D, Adachi H, Nagahara H, Shirai S, Takemura H, Takemura N, Mehrasa A, Higashino T, Yagi Y, Ikeda M Front Psychiatry. ;12:731137..2021.9.13
7 Case Report: Usefulness of Biomarkers for Alzheimer's Disease in Two Cases With Very-Late-Onset Schizophrenia-Like Psychosis Satake Y, Kanemoto H, Yoshiyama K, Nakahama R, Matsunaga K, Shimosegawa E, Morihara T, Hashimoto M, Ikeda M Front Psychiatry. ;12:7426592021.9.14
8 Dementia with Lewy bodies research consortia: A global perspective from theISTAART Lewy Body Dementias Professional Interest Area working group. D'Antonio F, Kane JPM, Ibañez A, Lewis SJG, Camicioli R, Wang H, Yu Y, ZhangJ, Ji Y, Borda MG, Kandadai RM, Babiloni C, Bonanni L, Ikeda M, Boeve BF,
Leverenz JB, Aarsland D
ISTAART Lewy body dementias Consortia Working Group., AlzheimersDement (Amst).;13(1):e12235. 2021.9.14
9 Effect of different parietal hypoperfusion on neuropsychological characteristics in mild cognitive impairment.
 
Yamaguchi T, Tabuchi H, Ito D, Saito N, Yamagata B, Konishi M, Takebayashi M, Ikeda M, Mimura M Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society 21(4) 618-626 2021.7
10 No adverse events were observed in clozapine-treated patients on extended hematologic monitoring intervals during the coronavirus pandemic in four psychiatric centers in Japan.

Hata M, Fujimoto M, Kanai K, Yoshiyama Kenji, Nakatani Y, Nakabayashi D, Maemura S, Kawata S Hakozaki T, Nishikura S, Umemoto A, Sasada T, Iwata K, Tanaka H, Mamoto A, Toi Y, Taniguchi N, Saito M, Kimura Y, Kishimoto K, Hayami M, Ikeda M Neuropsychopharmacology reports 41(2) 179-184 2021.6
11 The porphyrin TMPyP4 inhibitselongation during the noncanonical translation of the FTLD/ALS-associated GGGGCCrepeat in the C9orf72 gene. Mori K, Gotoh S, Yamashita T, Uozumi R, Kawabe Y, Tagami S, Kamp F, NuscherB, Edbauer D, Haass C, Nagai Y, Ikeda M. J Biol Chem; 297(4):101120. 2021.10
12 Normalized Power Variance: A New Field Orthogonal to Power in EEG Analysis Aoki Y, Kazui H, Pascual-Marqui R.D, Bruña R, Yoshiyama K, Wada T, Kanemoto H, Suzuki Y, Suehiro T, Satake Y, Yamakawa M, Hata M, Canuet L, Ishii R, Iwase M, Ikeda M Research Square, 2021.7
13 Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study Kanemoto H, Mori E, Tanaka T, Suehiro T, Yoshiyama K, Suzuki Y, Kakeda K, Wada T, Hosomi K, Kishima H, Kazui H, Hashimoto M, Ikeda M International Psychogeriatrics (17)1-9 2021.8.
14 Clinical profiles of people with dementia exhibiting with neuropsychiatric symptoms admitted to mental hospitals: A multicenter prospective survey in Japan.

Hozumi A, Tagai K, Shinagawa S, Kamimura N, Shigenobu K, Kashibayashi T, Azuma S, Yoshiyama K, Hashimoto M, Ikeda M, Shigeta M, Kazui H Geriatrics & gerontology international 2021.7.26
15 Treatment Efficacy and Acceptabilityof Pharmacotherapies for Dementia with Lewy Bodies: A Systematic Review and Network Meta-Analysis.

Chu CS, Yang FC, Tseng PT, Stubbs B, Dag A, Carvalho AF, Thompson T, Tu YK, Yeh TC, Li DJ, Tsai CK, Chen TY, Ikeda M Archives of gerontology and geriatrics 96 104474-104474 2021.7.2
16 Repurposing bromocriptine for Aβ metabolism in Alzheimer'sdisease (REBRAnD) study: randomised placebo-controlled double-blind comparativetrial and open-label extension trial to investigate the safety and efficacy ofbromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations. Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R,Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T,Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K,Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R,Tomimoto H, Inoue H. BMJOpen. 30;11(6):e051343 ; PMCID: PMC8246358., 2021.6
17 Neural networks associated with quality of life in patients with Parkinson's disease.

Nakano T, Kajiyama Y, Revankar GS, Hashimoto R, Watanabe Y, Kishima H, Ikeda M, Mihara M, Mochizuki H, Hattori N. Parkinsonism & related disorders 89 6-12 2021.6.17
18 Association of weekday-to-weekend sleep differences and stress response among a Japanese working population: a cross-sectional study.
 
Adachi H, Yamamoto R, Fujino R, Kanayama D, Sakagami Y, Akamine S, Marutani N, Yanagida K, Mamiya Y, Koyama M, Shigedo Y, Sugita Y, Mashita M, Nakano N, Watanabe K, Ikeda M, Kudo T. Sleep medicine 82 159-164 2021.6
19 Case Report: De Clerambault's Syndrome in Dementia With Lewy Bodies Suehiro T, Satake Y, Hashimoto M, Ikeda M. Front Psychiatry. 10;12:665868, 2021.6
20 Economic Burden of Alzheimer's Disease Dementia in Japan.

Ikeda S, Mimura M, Ikeda M, Wada-Isoe K, Azuma M, Inoue S, Tomita K Journal of Alzheimer's disease : JAD 81(1) 309-319, 2021
21 Catatonia associated with late-life psychosis successfully treated with lithium: a case report.

Sugawara H, Takamatsu J, Hashimoto M, Iwase M, Ikeda M Annals of general psychiatry 20(1) 14-14 2021.2.18
22 Clinical features of behavioral symptoms in patients with semantic dementia: Does semantic dementia cause autistic traits?

Sakuta S, Hashimoto M, Ikeda M, Koyama A, Takasaki A, Hotta M, Fukuhara R, Ishikawa T, Yuki S, Miyagawa Y, Hidaka Y, Kaneda K, Takebayashi M PloS one 16(2) e0247184, 2021
23 Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration.


Kawakami I, Arai T, Shinagawa S, Niizato K, Oshima K, Ikeda M International journal of geriatric psychiatry 36(1) 38-45 2021.1
24 Training and education in digital psychiatry: A perspective from Asia-Pacific region Orsolini L, Jatchavala C, Multazam N. I, Ransing R, Satake Y, Shoib S, Shah B, Ullah I, Volpe U Asia Pac Psychiatry. 2021 Dec 7;e12501.
25 The beneficial effect of physical activity on cognitive function in community-dwelling older persons with locomotive syndrome Nakamura M, Imaoka M, Hashizume H, Tazaki F, Hida M, Nakao H, Omizu T, Kanemoto H, Takeda M PeerJ. 2021 Oct 15;9:e12292
26 Cerebrospinal fluid amyloid beta and response of cognition to a tap test in idiopathic normal pressure hydrocephalus: a case-control study Kanemoto H, Mori E, Tanaka T, Suehiro T, Yoshiyama K, Suzuki Y, Kakeda K, Wada T, Hosomi K, Kishima H, Kazui H, Hashimoto M, Ikeda M Int Psychogeriatr. 2021 Aug 17:1-9
27 Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations Takayuki Kondo, Haruhiko Banno, Taro Okunomiya, Yoko Amino, Kayoko Endo, Akiyoshi Nakakura, Ryuji Uozumi, Akemi Kinoshita, Harue Tada, Satoshi Morita, Hidehiro Ishikawa, Akihiro Shindo, Ken Yasuda, Yosuke Taruno, Takakuni Maki, Takashi Suehiro, Kohji Mori, Manabu Ikeda, Koji Fujita, Yuishin Izumi, Kazutomi Kanemaru, Kenji Ishii, Kazue Shigenobu, Yumiko Kutoku, Yoshihide Sunada, Shinobu Kawakatsu, Shunji Shiota, Toshifumi Watanabe, Osamu Uchikawa, Ryosuke Takahashi, Hidekazu Tomimoto, Haruhisa Inoue BMJ Open 2021 Jun 30;11(6):e051343.
2020 1 The RNA exosome complex degrades expanded hexanucleotide repeat RNA in C9orf72 FTLD/ALS. Kawabe Y, Mori K, Yamashita T, Gotoh S, Ikeda M. EMBO J. 2020 Aug 24:e102700. doi: 10.15252/embj.2019102700.
2 Renal Function is Associated with Blood Neurofilament Light Chain Level in Older Adults Akamine S, Marutani N, Kanayama D, Gotoh S, Maruyama R, Yanagida K, Sakagami Y, Mori K, Adachi H, Kozawa J, Maeda N, Otsuki M, Matsuoka T, Iwahashi H, Shimomura I, Ikeda M, Kudo T. Scientific Reports 10:20350, 2020
3 The influence of the COVID-19 outbreak on the lifestyle of older patients with dementia or mild cognitive impairment. Hashimoto M, Suzuki M, Hotta M, Nagase A, Yamamoto Y, Hirakawa N, Satake Y, Nagata Y, Suehiro T, Kanemoto H, Yoshiyama K, Mori E, Ikeda M. Frontiers in psychiatry 11:570580, 2020
4 Prevalence and subtype distribution of early-onset dementia in Japan. Awata S, Edahiro A, Arai T, Ikeda M, Ikeuchi T, Kawakatsu S, Konagaya Y, Miyanaga K, Ota H, Suzuki K, Tanimukai S, Utsumi K, Kakuma T. Psychogeriatrics. 2020 Nov, 20:817-823. doi: 10.1111/psyg.12596.
5 Distinct early symptoms in neuropathologically proven frontotemporal lobar degeneration. Kawakami I, Arai T, Shinagawa S, Niizato K, Oshima K, Ikeda M. Int J Geriatr Psychiatry. 2020 Aug 3. doi: 10.1002/gps.5387. Online ahead of print.
6 Normalized power variance of eLORETA at high-convexity area predicts shunt response in idiopathic normal pressure hydrocephalus. Aoki Y, Kazui H, Bruña R, Pascual-Marqui RD, Yoshiyama K, Wada T, Kanemoto H, Suzuki Y, Suehiro T, Matsumoto T, Kakeda K, Hata M, Canuet L, Ishii R, Iwase M, Ikeda M. Sci Rep. 2020 Aug 3;10(1):13054. doi: 10.1038/s41598-020-70035-9
7 Psychogeriatrics in a World with COVID-19. Sano M, Lapid M, Ikeda M, Mateos R, Wang H, Reichman WE. Int Psychogeriatr. 2020 Oct, 32:1101-1105 doi: 10.1017/S104161022000126X.
8 The behavioral pattern of patients with frontotemporal dementia during the COVID-19 pandemic. Suzuki M, Hotta M, Nagase A, Yamamoto Y, Hirakawa N, Satake Y, Nagata Y, Suehiro T, Kanemoto H, Yoshiyama K, Mori E, Hashimoto M, Ikeda M. Int Psychogeriatr. 2020 Oct. 32:1231-1234 doi: 10.1017/S104161022000109X.
9 Loneliness and social isolation during the COVID-19 pandemic. Hwang TJ, Rabheru K, Peisah C, Reichman W, Ikeda M. Int Psychogeriatr. 2020 Oct, 32:1217-1220 doi: 10.1017/S1041610220000988.
10 Thalamic pulvinar metabolism, sleep disturbances, and hallucinations in dementia with Lewy bodies: Positron emission tomography and actigraphy study. Kanemoto H, Kazui H, Adachi H, Yoshiyama K, Wada T, Nomura KT, Shimosegawa E, Ikeda M. Int J Geriatr Psychiatry. 2020 Aug;35(8):934-943. doi: 10.1002/gps.5315. Epub 2020 Jun 8
11 Age-Related Changes in Instrumental and Basic Activities of Daily Living Impairment in Older Adults with Very Mild Alzheimer's Disease. Tabira T, Hotta M, Murata M, Yoshiura K, Han G, Ishikawa T, Koyama A, Ogawa N, Maruta M, Ikeda Y, Mori T, Yoshida T, Hashimoto M, Ikeda M. Dement Geriatr Cogn Dis Extra. 2020 Mar 24;10(1):27-37. doi: 10.1159/000506281. eCollection 2020 Jan-Apr
12 Non-fluent/Agrammatic Variant of Primary Progressive Aphasia with Generalized Auditory Agnosia. Watanabe H, Ikeda M, Mori E. Front Neurol, Jun 26;11:519. doi: 10.3389/fneur.2020.00519. eCollection 2020.PMID: 32676050
13 Prodromal DLB Diagnostic Study Group. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P. Neurology 2020 Apr 2. pii: 10.1212/WNL.0000000000009323. doi: 10.1212/WNL.0000000000009323. [Epub ahead of print]
14 Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Ducharme S, Dols A, Laforce R, Devenney E, Kumfor F, van den Stock J, Dallaire-Théroux C, Seelaar H, Gossink F, Vijverberg E, Huey E, Vandenbulcke M, Masellis M, Trieu C, Onyike C, Caramelli P, de Souza LC, Santillo A, Waldö ML, Landin-Romero R, Piguet O, Kelso W, Eratne D, Velakoulis D, Ikeda M, Perry D, Pressman P, Boeve B, Vandenberghe R, Mendez M, Azuar C, Levy R, Le Ber I, Baez S, Lerner A, Ellayosyula R, Pasquier F, Galimberti D, Scarpini E, van Swieten J, Hornberger M, Rosen H, Hodges J, Diehl-Schmid J, Pijnenburg Y. Brain. 2020 Jun 1; 143(6):1632-1650 doi: 10.1093/brain/awaa018. [Epub ahead of print]
15 Plasma levels of matrix metalloproteinase-9 (MMP-9) are associated with cognitive performance in patients with schizophrenia. Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R. Neuropsychopharmacology Reports, 2020 Jun;40(2):150-156 doi: 10.1002/npr2.12098.
16 Comparison of eye movements in schizophrenia and autism spectrum disorder. Shiino T,Miura K,Fujimoto M,Kudo N,Yamamori H,Yasuda Y,Ikeda M,Hashimoto R. Neuropsychopharmacol Rep 40(1) 92-95 2020 Mar
17 Relationship between executive dysfunction and neuropsychiatric symptoms and impaired instrumental activities of daily living among patients with very mild Alzheimer's disease. Ikezaki H, Hashimoto M, Ishikawa T, Fukuhara R, Tanaka H, Yuki S, Kuribayashi K, Hotta M, Koyama A, Ikeda M, Takebayashi M. Int J Geriatr Psychiatry. 2020 Aug;35(8):877-887. doi: 10.1002/gps.5308. Epub 2020 Apr 21
18 Research criteria for the diagnosis of prodromal dementia with Lewy bodies. McKeith IG, Ferman TJ, Thomas AJ, Blanc F, Boeve BF, Fujishiro H, Kantarci K, Muscio C, O'Brien JT, Postuma RB, Aarsland D, Ballard C, Bonanni L, Donaghy P, Emre M, Galvin JE, Galasko D, Goldman JG, Gomperts SN, Honig LS, Ikeda M, Leverenz JB, Lewis SJG, Marder KS, Masellis M, Salmon DP, Taylor JP, Tsuang DW, Walker Z, Tiraboschi P. Neurology 2020 Apr 28;94(17):743-755 doi: 10.1212/WNL.0000000000009323.
19 Gait characteristics measured with a standard smartphone, muscle weakness, and benzodiazepine in chronic psychiatric patients: a preliminary study Kanemoto H, Yukawa T, Sakoishi Y, Kawasaki T Cognition & Rehabilitation 1(1):67-73, 2020
2019 1 Cerebral microbleeds are associated with cerebral hypoperfusion in patient's with Alzheimer's disease Hatada Y, Hashimoto M, Shiraishi S, Ishikawa T, Fukuhara R, Yuki S, Tanaka H, Miyagawa Y, Kitajima M, Uetani H, Tsunoda N, Koyama A, Ikeda M J Alzheimers Dis. 2019;71(1):273-280
2 Logopenic progressive aphasia with neologism: a case report Watanabe HIkeda M, Mori E BMC Neurol. 2019 Nov 25;19(1):299.
3 Genetic Interaction of APOE and FGF1 is associated with memory impairment and hippocampal atrophy in Alzheimer's Disease Chang YT, Kazui H, Ikeda M, Huang CW, Huang SH, Hsu SW, Chang WN, Chang CC Aging Dis. 2019 Jun 1;10(3):510-519.
4 Eye movements characteristics of schizophrenia and their association with cortical thickness Morita K, Miura K, Fujimoto M, Yamamori H, Yasuda Y, Kudo N, Azechi H, Okada N, Koshiyama D, Shiino T, Fukunaga M, Watanabe Y, Ikeda M, Kasai K, Hashimoto R Psychiatry Clin Neurosci 73 : 509-509, 2019
5 Changes in brain morphology in patients in the preclinical stage of idiopathic normal pressure hydrocephalus. Suehiro T, Kazui H, Kanemoto H, Yoshiyama K, Sato S, Suzuki Y, Azuma S, Matsumoto T, Kishima H, Ishii K, Ikeda M Psychogeriatrics 19 : 557-565, 2019
6 Cerebral blood flow and Alzheimer's disease-related biomarkers in cerebrospinal fluid in idiopathic normal pressure hydrocephalus Azuma S, Kazui H, Kanemoto H, Suzuki Y, Sato S, Suehiro T, Matsumoto T, Yoshiyama K, Kishima H, Shimosegawa E, Tanaka T, Ikeda M Psychogeriatrics 19 : 527-538, 2019
7 Short-term meditation modulates EEG activity in subjects with post-traumatic residual disabilities Hata M, Hayashi N, Ishii R, Canuet L, Pascual-Marqui RD, Aoki Y, Ikeda S, Sakamoto T, Iwata M, Kimura K, Iwase M, Ikeda M, Ito T Clin Neurophysiol Pract 4 : 30-36, 2019
8 Emergence of artistic talent in progressive nonfluent aphasia: a case report Hamauchi A, Hidaka Y, Kitamura I, Yatabe Y, Hashimoto M, Yonehara T, Fukuhara R, Ikeda M Psychogeriatrics 19 : 601-604, 2019
9 Eye movement abnormalities and their association with cognitive impairments in schizophrenia Morita K, Miura K, Fujimoto M, Yamamori H, Yasuda Y, Kudo N, Azechi H, Okada N, Koshiyama D, Ikeda M, Kasai K, Hashimoto R Res. 2019 Jul;209:255-262.
10 EEG Resting-State Networks in Dementia with Lewy Bodies Associated with Clinical Symptoms Aoki Y, Kazui H, Pascal-Marqui RD, Ishii R, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Hata M, Canuet L, Iwase M, Ikeda M Neuropsychobiology 77 : 206-218, 2019
11 APOE-MS4A genetic interactions are associated with executive dysfunction and network abnormality in clinically mild Alzheimer's disease Chang YT, Mori E, Suzuki M, Ikeda M, Huang CW, Lee JJ, Chang WN, Chang CC Neuroimage Clin. 2019;21:101621.
12 Apathy and right caudate perfusion in idiopathic normal pressure hydrocephalus: a case-control study. Kanemoto H, Kazui H, Suehiro T, Kishima H, Suzuki Y, Sato S, Azuma S, Matsumoto T, Yoshiyama K, Shimosegawa E, Tanaka T, Ikeda M Int J Geriatr Psychiatry. 2019 Mar;34(3):453-462.
13 EEG Resting-State Networks Responsible for Gait Disturbance Features in Idiopathic Normal Pressure Hydrocephalus. Aoki Y, Kazui H, Pascual-Marqui RD, Ishii R, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Azuma S, Suehiro T, Matsumoto T, Hata M, Canuet L, Iwase M, Ikeda M Clin EEG Neurosci. 2019 May;50(3):210-218.
2018 1 Clinical features of auditory hallucinations in patients with DLB: A soundtrack of visual hallucinations Tsunoda N, Hashimoto M, Ishikawa T, Fukuhara R,Yuki S, Tanaka H, Hatada Y, Miyagawa Y, Ikeda M J Clin Psychiatry 2018 May/Jun;79(3).
2 Caregiver Burden in Semantic Dementia with Right- and Left-Sided Predominant Cerebral Atrophy and in Behavioral-Variant Frontotemporal Dementia. Koyama A, Hashimoto M, Fukuhara R, Ichimi N, Takasaki A, Matsushita M, Ishikawa T, Tanaka H, Miyagawa Y, Ikeda M. Dement Geriatr Cogn Dis Extra 8 :128-137, 2018
3 Abnormalities of eye movement are associated with work hours in schizophrenia. Morita K, Miura K, Fujimoto M, Shishido E, Shiino T, Takahashi J, Yamamori H, Yasuda Y, Kudo N, Hirano Y, Koshiyama D, Okada N, Ikeda M, Onitsuka T, Ozaki N, Kasai K, Hashimoto R. Schizophr Res. 2018 Dec;202:420-422.
4 Alpha event-related synchronization after eye closing differs in Alzheimer's disease and dementia with Lewy bodies: a magnetoencephalography study. Hata M, Kurimoto R, Kazui H, Ishii R, Canuet L, Aoki Y, Ikeda S, Azuma S, Suehiro T, Sato S, Suzuki Y, Kanemoto H, Yoshiyama K, Iwase M, Ikeda M. Psychogeriatrics. 18 : 202-208, 2018
5 Advantages of different care services for reducing neuropsychiatric symptoms in dementia patients. Suzuki Y, Kazui H, Yoshiyama K, Azuma S, Kanemoto H, Sato S, Suehiro T, Ikeda M. Psychogeriatrics. 2018 Jul;18(4):252-258
6 Usefulness of carer-held records to support informal caregivers of patients with dementia who live at home. Sato S, Kazui H, Shimizu Y, Yoshida T, Yoshiyama K, Kanemoto H, Suzuki Y, Morikami T, Fujisue H, Tanaka T, Ikeda M. Psychogeriatrics18 :166-174, 2018
7 Plasma Levels of Soluble Tumor Necrosis Factor Receptor 2 (sTNFR2) Are Associated with Hippocampal Volume and Cognitive Performance in Patients with Schizophrenia. Kudo N, Yamamori H, Ishima T, Nemoto K, Yasuda Y, Fujimoto M, Azechi H, Niitsu T, Numata S, Ikeda M, Iyo M, Ohmori T, Fukunaga M, Watanabe Y, Hashimoto K, Hashimoto R. Int J Neuropsychopharmacol 21 : 631-639, 2018
8 Frequency of mental disorders among chronic pain patients with or without fibromyalgia in Japan. Miki K, Nakae A, Shi K, Yasuda Y, Yamamori H, Fujimoto M, Ikeda M, Shibata M, Yukioka M, Hashimoto R Neuropsychopharmacol Rep. 38(4):167-174, 2018
9 Are saving appearance responses typical communication patterns in Alzheimer's disease? Matsushita M, Yatabe Y, Koyama A, Katsuya A, Ijichi D, Miyagawa Y, Ikezaki H, Furukawa N, Ikeda M, Hashimoto M. PLoS One. 2018 May 23;13(5):e0197468.
10 Integrated analysis of human genetic association study and mouse transcriptome suggests LBH and SHF genes as novel susceptible genes for amyloid-β accumulation in Alzheimer's disease. Yamaguchi-Kabata Y, Morihara T, Ohara T, Ninomiya T, Takahashi A, Akatsu H, Hashizume Y, Hayashi N, Shigemizu D, Boroevich KA, Ikeda M, Kubo M, Takeda M, Tsunoda T. Hum Genet. 2018 Jul 13.137(6-7):521-533
11 EEG resting state networks responsible for gait disturbance features in idiopathic normal pressure hydrocephalus Aoki Y, Kazui H, Pascual-Marqui RD, Ishii R, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Azuma S, Suehiro T, Matsumoto T, Hata M, Canuet L, Iwase M, Ikeda M. Clin EEG Neurosci. 2018 [Epub ahead of print].
2017 1 Effects of donepezil on sleep disturbances in patients with dementia with Lewy bodies: An open-label study with actigraphy. Kazui H, Adachi H, Kanemoto H, Yoshiyama K, Wada T, Tokumasu Nomura K, Tanaka T, Ikeda M. Psychiatry Res. May, 251:312-318, 2017
2 Identification of small peptides in human cerebrospinal fluid upon amyloid-βdegradation. Mizuta N, Yanagida K, Kodama T, Tomonaga T, Takami M, Oyama H, Kudo T, Ikeda M, Takeda M, Tagami S, Okochi M Neurodegener Dis, 17:103-109, 2017
3 Why do people with dementia pretend to know the correct answer? A qualitative study on the behaviour of toritsukuroi to keep up appearances Matsushita M, Yatabe Y, Koyama A, Ueno Y, Ijichi D, Ikezaki H, Hashimoto M, Furukawa N, Ikeda M Psychogeriatrics 17(6):377-381, 2017
4 Face-specific memory deficits and changes in eye scanning patterns among patients with amnestic mild cognitive impairment Kawagoe T, Matsushita M, Hasimoto M, Ikeda M, Sekiyama K Sci Rep. 2017 Oct 30;7(1):14344. doi: 10.1038/s41598-017-14585-5.
5 The creation and dissemination of downloadable information on dementia and driving from a social health perspective Arai Y, Arai A, Mizuno Y, Kamimura N, Ikeda M Psychogeriatrics 17 : 262-266, 2017
6 Violation of Laws in Frontotemporal Dementia: A Multicenter Study in Japan Shinagawa S, Shigenobu K, Tagai K, Fukuhara R, Kamimura N, Mori T, Yoshiyama K, Kazui H, Nakayama K, Ikeda M J Alzheimers Dis 57(4):1221-1227, 2017
7 Gustatory dysfunction as an early symptom of semantic dementia Sakai M, Kazui H, Shigenobu K, Komori K, Ikeda M, Nishikawa T Dement Geriatr Cogn Disord Extra (in press)
8 Neural basis of apathy in patients with amnestic mild cognitive impairment. Kazui H, Takahashi R, Yamamoto Y, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Azuma S, Suehiro T, Shimosegawa E, Ishii K, Tanaka T. J Alzheimers Dis. 55(4):1403-16, 2016
9 Use of T1-weighted/T2-weighted magnetic resonance ratio to elucidate changes due to amyloid β accumulation in cognitively normal subjects. Yasuno F, Kazui H, Morita N, Kajimoto K, Ihara M, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Iida H, Kishimoto T, Nagatsuka K Neuroimage Clin 13: 209-214, 2017
10 Mutual effect of cerebral amyloid β and peripheral lymphocytes in cognitively normal older individuals. Yasuno F, Kazui H, Kajimoto K, Ihara M, Morita N, Taguchi A, Yamamoto A, Matsuoka K, Takahashi M, Nakagawara J, Tsuji M, Iida H, Kishimoto T, Nagatsuka K Int J Geriatr Psychiatry: Jan 23. doi: 10.1002/gps.4660. [Epub ahead of print], 2017
11 Disability risk or unimproved symptoms following shunt surgery in patients with idiopathic normal-pressure hydrocephalus: post hoc analysis of SINPHONI-2. Yamada S,Kimura T,Jingami N,Atsuchi M,Hirai O,Tokuda T,Miyajima M,Kazui H,Mori E,Ishikawa M,SINPHONI-2 Investigators J Neurosurg 126: 2002-2009,2017
12 Cost-effectiveness analysis of shunt surgery for idiopathic normal pressure hydrocephalus based on the SINPHONI and SINPHONI-2 trials Kameda M, Yamada S, Atsuchi M, Kimura T, Kazui H, Miyajima M, Mori E, Ishikawa M, Date I, SINPHONI and SINPHONI-2 Investigators Acta Neurochir (Wien) 159: 995-1003, 2017
13 Conversational assessment of cognitive dysfunction among residents living in long-term care facilities. Oba H, Sato S, Kazui H, Nitta Y, Nashitani T, Kamiyama A Int Psychogeriatr (In Press)
14 Cerebrospinal fluid biomarkers of Alzheimer's disease correlate with electroencephalography parameters assessed by exact low-resolution electromagnetic tomography (eLORETA). Hata M, Tanaka T, Kazui H, Ishii R, Canuet L, Pascual-Marqui RD, Aoki Y, Ikeda S, Sato S, Suzuki Y, Kanemoto H, Yoshiyama K, Iwase M. Clin EEG Neurosci. 48(5):338-47, 2016
2016 1 Differences of Behavioral and Psychological Symptoms of Dementia in Disease Severity in Four Major Dementias Kazui H, Yoshiyama K, Kanemoto H, Suzuki Y, Sato S, Hashimoto M, Ikeda M, Tanaka H, Hatada Y, Matsushita M, Nishio Y, Mori E, Tanimukai S, Komori K, Yoshida T, Shimizu H, Matsumoto T, Mori T, Kashibayashi T, Yokoyama K, Shimomura T, Kabeshita Y, Adachi H, Tanaka T PLoS One 11(6): e0161092, 2016 DOI: 10.1371/journal.pone.0161092
2 Malnutrition in Alzheimer's disease, dementia with Lewy bodies, and frontotemporal lobar degeneration: comparison using serum albumin, total protein, and hemoglobin level Koyama A, Hashimoto M, Tanaka H, Fujise N, Matsushita M, Miyagawa Y, Hatada Y, Fukuhara R, Hasegawa N, Todani S, Matsukuma K, Kawano M, Ikeda M PLoS One 11(6):e0157053, 2016 DOI:
10.1371/journal.pone.0157053
3 Increased plasma donepezil concentration improves cognitive function in patients with dementia with Lewy bodies: An exploratory pharmacokinetic/pharmacodynamic analysis in a phase 3 randomized controlled trial Mori E, Ikeda M, Nakai K, Nakagawa M, Miyagishi H, Nakagawa M, Kosaka K J Neuro Sciences 366 : 184-190, 2016 DOI:
10.1016/j.jns.2016.05.001
4 Pretreatment Cognitive Profile Likely to Benefit from Donepezil Treatment in Dementia with Lewy Bodies: Pooled Analyses of Two Randomized Controlled Trials Mori E, Ikeda M, Nakagawa M, Miyagishi H, Kosaka K Dement Geriatr Cogn Disord 42 : 58-68, 2016 DOI: 10.1159/000447586
5 Cross-cultural study of caregiver burden for Alzheimer's disease in Japan and Taiwan: result from Dementia Research in Kumamoto and Tainan (DeReKaT) Matsushita M, Pai MC, Jhou BS, Koyama A, Ikeda M International Psychogeriatrics 28 :1125-32, 2016 DOI: 10.1017/S104161021600003X
6 123I-MIBG myocardial scintigraphy for the evaluation of Lewy bodies disease: Are delayed images essential ? Is visual assessment useful ? Sakamoto F, Shiraishi S, Tsuda N, Ogasawara K, Yoshida M, Yuki H, Hashimoto M, Tomiguchi S, Ikeda M, Yamashita Y Br J Radiology 2016 Jun 10:20160144. (Epub ahead) DOI: 10.1259/bjr.20160144
7 The Pareidolia Test: A Simple Neuropsychological Test Measuring Visual Hallucination-Like Illusions Mamiya Y, Nishio Y, Watanabe H, Yokoi K, Uchiyama M, Baba T, Iizuka O, Kanno S, Kamimura N, Kazui H, Hashimoto M, Ikeda M, Takeshita C, Shimomura T, Mori E PLoS One. 2016 May 12;11(5):e0154713 DOI:
10.1371/journal.pone.0154713
8 Sleep disturbances are key symptoms of very early stage Alzheimer disease with behavioral and psychological symptoms: a Japan multi-center cross-sectional study (JBIRD). Kabeshita Y, Adachi H, Matsushita M, Kanemoto H, Sato S, Suzuki Y, Yoshiyama K, Shimomura T, Yoshida T, Shimizu H, Matsumoto T, Mori T, Kashibayashi T, Tanaka H, Hatada Y, Hashimoto M, Nishio Y, Komori K, Tanaka T, Yokoyama K, Tanimukai S, Ikeda M, Takeda M, Mori E, Kudo T, Kazui H. Int J Geriatr Psychiatry. 32(2):222-230, 2016
9 Classifying eating-related problems among institutionalized subjects with dementia Shinagawa S, Honda K, Kashibayashi T, Shigenobu K, Nakayama K, Ikeda M Psychiatry and Clinical Neurosciences 70 : 175-181, 2016 DOI:
10.1111/pcn.12375
10 Comparisons of prevalence and related factors of depression in middle-aged adults between urban and rural populations in Japan Fujise N, Abe Y, Fukunaga R, Nakagawa Y, Nishi Y, Koyama A, Ikeda M J affect disord 190 : 772-776, 2016 DOI:
10.1016/j.jad.2015.11.020
11 Decline of gustatory sensitivity with the progression of Alzheimer's disease Sakai M, Ikeda M, Kazui H, Shigenobu K, Nishikawa T International Psychogeriatrics 28 : 511-517, 2016 DOI: 10.1017/S1041610215001337
12 Diagnostic Significance of Cortical Superficial Siderosis for Alzheimer's Disease in Patients with Cognitive Impairment Inoue Y, Nakajima M, Uetani H, Hirai T, Ueda M, Kitajima M, Utsunomiya D, Watanabe M, Hashimoto M, Ikeda M, Yamashita Y, Ando, Y AJNR Am J Neuroradiol 37 : 223-227, 2016 DOI: 10.3174/ajnr.A4496
13 Comparison of driving behaviors between individuals with frontotemporal lobar degeneration and those with Alzheimer's disease Fujito R, Kamimura N, Ikeda M, Koyama A, Shimodera S, Morinobu S, Inoue S Psychogeriatrics 16 : 27-33, 2016 DOI:
10.1111/psyg.12115
14 Adequacy of using consensus guidelines for diagnosis of dementia with Lewy bodies in clinical trials for drug development Ikeda M, Mori E, Iseki E, Katayama S, Higashi Y, Hashimoto M, Miyagishi H, Nakagawa M, Kosaka K Dement Geriatr Cogn Disord 41 : 55-67, 2016 DOI: 10.1159/000441443
15 Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus. Kazui H,Kanemoto H,Yoshiyama K,Kishima H,Suzuki Y,Sato S,Suehiro T,Azuma S,Yoshimine T,Tanaka T. J Neurol Sci 369,236-241,2016.(IF 2.126)
16 Effect of lumbo-peritoneal shunt surgery on neuropsychiatric symptoms in patients with idiopathic normal pressure hydrocephalus. Kanemoto H,Kazui H(CA),Suzuki Y,Sato S,Kishima H,Yoshimine T,Yoshiyama K. J Neurol Sci 361,206-212,2016.(IF 2.126)
17 Functional connectivity assessed by resting state EEG correlates with cognitive decline of Alzheimer's disease - An eLORETA study. Hata M,Kazui H,Tanaka T,Ishii R,Canuet L,Pascual-Marqui R,Aoki Y,Ikeda S,Kanemoto H,Yoshiyama K. Clin Neurophysiol 127,1269-1278,2016.(IF 3.426)
18 High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study. Yasuno F,Kazui H,Morita N,Kajimoto K,Ihara M,Taguchi A,Yamamoto A,Matsuoka K,Kosaka J,Kudo T,Iida H,Kishimoto T,Nagatsuka K. Int J Geriatr Psychiatry 31,920-928,2016.(IF 2.699)
19 One-year outcome in patients with idiopathic normal-pressure hydrocephalus: comparison of lumboperitoneal shunt to ventriculoperitoneal shunt. Miyajima M,Kazui H,Mori E,Ishikawa M,on behalf of the SINPHONI-2 Investigators. J Neurosurg 125,1483-1492,2016.(IF 1.837)
20 A structural model of age,grey matter volumes, education, and personality traits. Kitamura S,Yasuno F,Yamamoto A,Kazui H,Kudo T,Matsuoka K,Kiuchi K,Kosaka J,Nagatsuka K,Iida H,Kishimoto T. Psychogeriatrics 16,46-53,2016.(IF 1.0)
21 Electrical stimulation of the parahippocampal gyrus for prediction of posthippocampectomy verbal memory decline. Tani N,Kishima H,Khoo HM,Yanagisawa T,Oshino S,Maruo T,Hosomi K,Hirata M,Kazui H,Nomura KT,Aly MM,Kato A,Yoshimine T. J Neurosurg 125,1053-1060,2016.(IF 1.837)
22 Default mode network connectivity in patients with idiopathic normal pressure hydrocephalus. Khoo HM,Kishima H,Tani N,Oshino S,Maruo T,Hosomi K,Yanagisawa T,Kazui H,Watanabe Y,Shimokawa T,Aso T,Kawaguchi A,Yamashita F,Saitoh Y,Yoshimine T. J Neurosurg 124,350-358, 2016.(IF 1.837)
23 Bladder recovery relates with increased mid-cingulate perfusion after shunt surgery in idiopathic normal-pressure hydrocephalus: a single-photon emission tomography study. Sakakibara R,Uchida Y,Ishii K,Hashimoto M,Ishikawa M,Kazui H,Yamamoto T,Uchiyama T,Tateno F,Kishi M,Tsuyusaki Y,Aiba Y,Tateno H,Nagao T,Terada H,Inaoka T,Members of SINPHONI (Study of Idiopathic Normal Pressure Hydrocephalus On Neurological Improvement). Int Urol Nephrol 48,169-174,2016.(IF 1.292)
24 Disease duration: the key to accurate CSF tap test in iNPH. Yamada S,Ishikawa M,Miyajima M,Atsuchi M,Kimura T,Kazui H,Mori E,SINPHONI-2 Investigators. Acta Neurol Scand Feb 29.doi: 10.1111/ane.12580.[Epub ahead of print],2016.(IF 2.559)
2013 1 Possible roles of the dominant uncinate fasciculus in naming objects: a case report of intraoperative electrical stimulation on a patient with a brain tumour Nomura K, Kazui H, Tokunaga H, Hirata M, Goto T, Goto Y, Hashimoto N, Yoshimine T, Takeda M Behav Neurol 27(2):229-34, 2013
2 Association between milder brain deformation before a shunt operation and improvement in cognition and gait in idiopathic normal pressure hydrocephalus Yamamoto D, Kazui H, Wada T, Nomura K, Sugiyama H, Shimizu Y, Yoshiyama K, Yoshida T, Kishima H, Yamashita F, Yoshimine T, Takeda M Dement Geriatr Cogn Disord 35(3-4):197-207, 2013
3 Predictors of prolonged hospital stay for the treatment of severe neuropsychiatric symptoms in patients with dementia: a cohort study in multiple hospitals Sugiyama H, Kazui H, Shigenobu K, Masaki Y, Hatta N, Yamamoto D, Wada T, Nomura K, Yoshiyama K, Tabushi K, Takeda M. Int Psychogeriatr 23:1-9, 2013
4 Reversibility of brain morphology after shunt operations and preoperative clinical symptoms in patients with idiopathic normal pressure hydrocephalus Wada T, Kazui H, Yamamoto D, Nomura K, Sugiyama H, Shimizu Y, Yoshida T, Yoshiyama K, Yamashita F, Kishima H, Yoshimine T, Takeda M. Psychogeriatrics 13(1):41-8, 2013
5 Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery Kazui H, Mori E, Ohkawa S, Okada T, Kondo T, Sakakibara R, Ueki O, Nishio Y, Ishii K, Kawaguchi T, Ishikawa M, Takeda M vJ Neurol Sci 328(1-2):64-9, 2013
2012 1 Distribution of Cortical Benzodiazepine Receptor Binding in Right-Handed Healthy Humans: A Voxel-Based Statistical Analysis of Iodine 123 Iomazenil SPECT with Partial Volume Correction Kato H, Shimosegawa E, Isohashi K, Kimura N, Kazui H, Hatazawa J AJNR Am J Neuroradiol 33(8):1458-63, 2012
2 Personality traits and schizophrenia: evidence from a case-control study and meta-analysis. Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Yamamori H, Iwase M, Kazui H, Takeda M Psychiatry Res 198(1):7-11, 2012
3 Classification of delusions in Alzheimer's disease and their neural correlates Nomura K, Kazui H, Wada T, Sugiyama H, Yamamoto D, Yoshiyama K, Shimosegawa E, Hatazawa J, Takeda M Psychogeriatrics 12(3):200-10, 2012
2011 1 Different characteristics of cognitive impairment in elderly schizophrenia and Alzheimer's disease in the mild cognitive impairment stage Kazui H, Yoshida T, Takaya M, Sugiyama H, Yamamoto D, Kito Y, Wada T, Nomura K, Yasuda Y, Yamamori H, Ohi K, Fukumoto M, Iike N, Iwase M, Morihara T, Tagami S, Shimosegawa E, Hatazawa J, Ikeda Y, Uchida E, Tanaka T, Kudo T, Hashimoto R, Takeda M Dement Geriatr Cogn Dis Extra 1(1):20-30, 2011
2 Effect of shunt operation on idiopathic normal pressure hydrocephalus patients in reducing caregiver burden: Evidence from SINPHONI Kazui H, Mori E, Hashimoto M, Ishikawa M, Hirono N, Takeda M Dement Geriatr Cogn Disord. 31(5): 363-70, 2011
3 Protein synthesis in the posterior cingulate cortex in Alzheimer's disease Yoshida T, Kazui H, Tokunaga H, Kito Y, Kubo Y, Kimura N, Morihara T, Shimosegawa E, Hatazawa J, Takeda M Psychogeriatrics11(1): 40-5, 2011
4 No association between the PCM1 gene and schizophrenia: a multi-center case-control study and a meta-analysis Hashimoto R, Ohi K, Yasuda Y, Fukumoto M, Yamamori H, Kamino K, Morihara T, Iwase M, Kazui H, Numata S, Ikeda M, Ueno S, Ohmori T, Iwata N, Ozaki N, Takeda M Schizophrenia Res129:80-84, 2011
5 The AKT1 gene is associated with attention and brain morphology in schizophrenia Ohi K, Hashimoto R, Yasuda Y, Fukumoto M, Nemoto K, Ohnishi T, Yamamori H, Takahashi H, Iike N, Kamino K, Yoshida T, Azechi M, Ikezawa K, Tanimukai H, Tagami S, Morihara T, Okochi M, Tanaka T, Kudo T, Iwase M, Kazui H, Takeda M World J Biol Psychiatry, 2011